Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v3.21.1
Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash $ 28,660,375 $ 6,835
Total current assets 28,660,375 6,835
Acquired patents, net 16,227 19,836
Total assets 28,676,602 26,671
Current liabilities    
Accounts payable & accrued interest 710,971 730,309
Unreimbursed expenses 59,367 11,626
Advance from related party/shareholder 275,154 635,154
Total current liabilities 1,045,492 1,377,089
Total liabilities 1,045,492 1,377,089
Stockholders' equity (deficit)    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,703,541 and 8,458,048 shares issued and outstanding as of December 31, 2020 and 2019, respectively 12,704 8,458
Preferred stock value
Additional paid-in capital 56,695,359 25,853,134
Accumulated deficit (29,076,953) (27,213,991)
Total stockholders' equity (deficit) 27,631,110 (1,350,418)
Total liabilities and stockholders' equity (deficit) 28,676,602 26,671
Series A Preferred Stock [Member]    
Stockholders' equity (deficit)    
Preferred stock value 1,521
Series B Preferred Stock [Member]    
Stockholders' equity (deficit)    
Preferred stock value 129
Series C Preferred Stock [Member]    
Stockholders' equity (deficit)    
Preferred stock value 67
Series D Preferred Stock [Member]    
Stockholders' equity (deficit)    
Preferred stock value $ 264